Canine and human cell researchers have discovered that cannabidiol is effective in fighting glioblastomas
Researchers who have studied canine and human cell samples have found that cannabidiol is effective in fighting a very aggressive form of brain cancer known as glioblastoma.
People diagnosed with glioblastoma generally have a poor prognosis, and recent advances in research have failed to significantly improve their survival rate.
"There is an urgent need to continue research and find new treatment options for patients with brain cancer," said Chase Gross, doctoral student in veterinary medicine and master of science at the University of Colorado State, in a press release. "Our work shows that CBD has the potential to provide an effective and synergistic treatment option for glioblastoma and that it should continue to be vigorously studied."
By publishing their findings in the FASEB Journal, Gross and his colleagues studied human and canine glioblastoma cells. They first tested the effects on these cells with CBD isolate, which is 100% CBD, and also with CBD extract, which also contains small amounts of other natural compounds.
After some research, scientists found that CBD slows the growth of glioblastoma cells taken from humans and dogs. It seems there is a significant difference between isolate and CBD extract regarding this effect.
“CBD has been studied with enthusiasm for its anti-cancer properties over the past decade,” Mr. Gross said. “Our study helps complete the in vitro puzzle, allowing us to move forward in studying the effects of CBD on glioblastoma in a clinical setting using live animal models. This could lead to new treatments that would help both people and dogs with this very serious cancer." page (in French).
Gross and his colleagues plan to evaluate the effects of CBD on animals with glioblastoma. While waiting for this research to be successful, they hope to begin clinical trials of CBD as a treatment for brain cancer in dogs at Colorado State University Veterinary Hospital.